company background image
ENZ

Enzo Biochem NYSE:ENZ Stock Report

Last Price

US$1.96

Market Cap

US$95.5m

7D

-1.0%

1Y

-42.0%

Updated

27 Nov, 2022

Data

Company Financials
ENZ fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

ENZ Stock Overview

Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology.

Enzo Biochem, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Enzo Biochem
Historical stock prices
Current Share PriceUS$1.96
52 Week HighUS$3.70
52 Week LowUS$1.90
Beta0.81
1 Month Change-6.22%
3 Month Change-21.91%
1 Year Change-42.01%
3 Year Change-26.04%
5 Year Change-79.28%
Change since IPO-28.83%

Recent News & Updates

Enzo Biochem appoints Patricia Eckert as interim CFO

Oct 20

Recent updates

Does Enzo Biochem (NYSE:ENZ) Have A Healthy Balance Sheet?

Oct 04
Does Enzo Biochem (NYSE:ENZ) Have A Healthy Balance Sheet?

Is Enzo Biochem (NYSE:ENZ) Using Debt In A Risky Way?

May 03
Is Enzo Biochem (NYSE:ENZ) Using Debt In A Risky Way?

Is Enzo Biochem (NYSE:ENZ) A Risky Investment?

Dec 17
Is Enzo Biochem (NYSE:ENZ) A Risky Investment?

Health Check: How Prudently Does Enzo Biochem (NYSE:ENZ) Use Debt?

Aug 24
Health Check: How Prudently Does Enzo Biochem (NYSE:ENZ) Use Debt?

Does Enzo Biochem (NYSE:ENZ) Have A Healthy Balance Sheet?

Mar 01
Does Enzo Biochem (NYSE:ENZ) Have A Healthy Balance Sheet?

Is Enzo Biochem, Inc. (NYSE:ENZ) Popular Amongst Insiders?

Feb 03
Is Enzo Biochem, Inc. (NYSE:ENZ) Popular Amongst Insiders?

If You Had Bought Enzo Biochem's (NYSE:ENZ) Shares Three Years Ago You Would Be Down 66%

Jan 08
If You Had Bought Enzo Biochem's (NYSE:ENZ) Shares Three Years Ago You Would Be Down 66%

Here's What We Think About Enzo Biochem's (NYSE:ENZ) CEO Pay

Dec 13
Here's What We Think About Enzo Biochem's (NYSE:ENZ) CEO Pay

Shareholder Returns

ENZUS HealthcareUS Market
7D-1.0%2.1%1.3%
1Y-42.0%9.3%-18.5%

Return vs Industry: ENZ underperformed the US Healthcare industry which returned 9.4% over the past year.

Return vs Market: ENZ underperformed the US Market which returned -18.5% over the past year.

Price Volatility

Is ENZ's price volatile compared to industry and market?
ENZ volatility
ENZ Average Weekly Movement8.8%
Healthcare Industry Average Movement8.2%
Market Average Movement7.4%
10% most volatile stocks in US Market15.6%
10% least volatile stocks in US Market3.3%

Stable Share Price: ENZ is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: ENZ's weekly volatility (9%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1976493Hamid Erfanianhttps://www.enzo.com

Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products segment develops, manufactures, and markets products and tools to clinical research, drug development, and bioscience research customers.

Enzo Biochem, Inc. Fundamentals Summary

How do Enzo Biochem's earnings and revenue compare to its market cap?
ENZ fundamental statistics
Market CapUS$95.49m
Earnings (TTM)-US$18.26m
Revenue (TTM)US$107.07m

0.9x

P/S Ratio

-5.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ENZ income statement (TTM)
RevenueUS$107.07m
Cost of RevenueUS$65.10m
Gross ProfitUS$41.97m
Other ExpensesUS$60.23m
Earnings-US$18.26m

Last Reported Earnings

Jul 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.37
Gross Margin39.20%
Net Profit Margin-17.06%
Debt/Equity Ratio7.9%

How did ENZ perform over the long term?

See historical performance and comparison